Harbor Capital Advisors Inc. lifted its stake in Booz Allen Hamilton Holding Co. (NYSE:BAH – Free Report) by 80.0% during the 3rd quarter, HoldingsChannel reports. The fund owned 16,411 shares of the business services provider’s stock after buying an additional 7,292 shares during the period. Harbor Capital Advisors Inc.’s holdings in Booz Allen Hamilton were worth $2,671,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors have also modified their holdings of BAH. Mediolanum International Funds Ltd bought a new stake in Booz Allen Hamilton in the first quarter valued at about $2,044,000. Cetera Investment Advisers lifted its holdings in Booz Allen Hamilton by 142.5% in the first quarter. Cetera Investment Advisers now owns 28,615 shares of the business services provider’s stock valued at $4,248,000 after buying an additional 16,815 shares during the period. Sei Investments Co. lifted its holdings in Booz Allen Hamilton by 47.4% in the first quarter. Sei Investments Co. now owns 168,377 shares of the business services provider’s stock valued at $24,995,000 after buying an additional 54,180 shares during the period. State Board of Administration of Florida Retirement System lifted its holdings in Booz Allen Hamilton by 2.9% in the first quarter. State Board of Administration of Florida Retirement System now owns 149,998 shares of the business services provider’s stock valued at $22,266,000 after buying an additional 4,264 shares during the period. Finally, CreativeOne Wealth LLC bought a new stake in Booz Allen Hamilton in the first quarter valued at approximately $955,000. Institutional investors and hedge funds own 91.82% of the company’s stock.
Booz Allen Hamilton Price Performance
NYSE:BAH opened at $182.62 on Tuesday. Booz Allen Hamilton Holding Co. has a 52 week low of $122.59 and a 52 week high of $189.13. The firm has a market cap of $23.33 billion, a price-to-earnings ratio of 28.67, a P/E/G ratio of 2.49 and a beta of 0.58. The firm’s 50-day simple moving average is $161.91 and its 200 day simple moving average is $154.99. The company has a debt-to-equity ratio of 2.76, a quick ratio of 1.55 and a current ratio of 1.56.
Booz Allen Hamilton Dividend Announcement
Insider Buying and Selling
In other Booz Allen Hamilton news, EVP Richard Crowe sold 4,243 shares of the firm’s stock in a transaction dated Thursday, October 24th. The shares were sold at an average price of $165.00, for a total value of $700,095.00. Following the transaction, the executive vice president now directly owns 25,496 shares of the company’s stock, valued at $4,206,840. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, CFO Matthew Calderone sold 4,065 shares of Booz Allen Hamilton stock in a transaction that occurred on Thursday, October 24th. The shares were sold at an average price of $165.00, for a total transaction of $670,725.00. Following the sale, the chief financial officer now directly owns 29,618 shares in the company, valued at $4,886,970. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Richard Crowe sold 4,243 shares of Booz Allen Hamilton stock in a transaction that occurred on Thursday, October 24th. The stock was sold at an average price of $165.00, for a total transaction of $700,095.00. Following the sale, the executive vice president now owns 25,496 shares in the company, valued at approximately $4,206,840. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 12,173 shares of company stock valued at $1,989,220. 1.59% of the stock is owned by company insiders.
Analyst Ratings Changes
BAH has been the subject of several recent analyst reports. TD Cowen lowered their target price on shares of Booz Allen Hamilton from $185.00 to $165.00 and set a “buy” rating for the company in a research note on Monday, July 29th. StockNews.com raised shares of Booz Allen Hamilton from a “sell” rating to a “hold” rating in a research note on Wednesday, October 30th. The Goldman Sachs Group upped their target price on shares of Booz Allen Hamilton from $174.00 to $196.00 and gave the company a “buy” rating in a research note on Thursday, October 10th. Truist Financial increased their price objective on shares of Booz Allen Hamilton from $165.00 to $185.00 and gave the stock a “hold” rating in a research report on Monday, October 28th. Finally, Jefferies Financial Group downgraded shares of Booz Allen Hamilton from a “buy” rating to a “hold” rating and increased their price objective for the stock from $180.00 to $190.00 in a research report on Monday. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat, Booz Allen Hamilton currently has a consensus rating of “Hold” and an average target price of $180.63.
Check Out Our Latest Stock Analysis on Booz Allen Hamilton
Booz Allen Hamilton Company Profile
Booz Allen Hamilton Holding Corporation provides management and technology consulting, analytics, engineering, digital solutions, mission operations, and cyber services to governments, corporations, and not-for-profit organizations in the United States and internationally. It focuses on artificial intelligence services comprising of machine learning, predictive modeling, automation and decision analytics, and quantum computing.
See Also
- Five stocks we like better than Booz Allen Hamilton
- Insider Buying Explained: What Investors Need to Know
- Intel: Is Now the Time to Be Brave?Â
- 3 Healthcare Dividend Stocks to Buy
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- 3 Warren Buffett Stocks to Buy Now
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Want to see what other hedge funds are holding BAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Booz Allen Hamilton Holding Co. (NYSE:BAH – Free Report).
Receive News & Ratings for Booz Allen Hamilton Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Booz Allen Hamilton and related companies with MarketBeat.com's FREE daily email newsletter.